Mosquito repellents clothing Technology
Diseases such as Zika, Dengue fever, Yellow fever, and Chikungunya are transmitted by day-biting mosquitoes called Ae. Aegypti. These vectors are not effectively controlled by the existing tools such as long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) there was a need for additional complementary tools. We have exploited mosquito behaviour by the use of clothing technology which contains repellent patches treated with natural extracts from Gum trees and Cymbopogon known to have insect-repelling properties and contains wash resistance technology. As a platform to release highly effective wide-area spatial mosquito repellents, creating full-time protection against both day and night biting mosquitoes.
MOSQUITOES spread diseases to millions of people around the world, yet they remain poorly understood by most. Despite substantial declines in malaria burden over the past 15 years, mostly achieved by vector control inside houses with long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), substantial residual transmission persists because many vector mosquitoes can bite people outdoors where these interventions offer no direct protection. However, mosquito bite exposure could also occur while people are indoor before bedtime, when they are eating, socializing, and school children are studying. On the other hand, diseases such as Zika, Dengue fever, Yellow fever, and Chikungunya are transmitted by day-biting mosquitoes called Ae. Aegypti. These vectors are not effectively controlled by the existing tools such as LLINs and IRS, necessitating the need for additional complementary tools.
We are exploiting mosquito behaviour and by the use clothing technology which contains repellent patches treated with natural extracts from Gum trees and Cymbopogon known to have insect-repelling properties and contain long lasting washing resistance technology. As a platform to release highly effective wide-area spatial mosquito repellents, creating full-time protection against both day-biting and night-biting mosquitoes at individual and household level.
Long Lasting Insecticidal Nets (LLINs) and Indoor residual spraying or (IRS) are widely and mostly used methods for vector control in Sub-Saharan Africa. Due to frequent use of these interventions in some regions mosquitoes have developed insecticide resistance and behavioural change that caused some mosquitoes to feed earlier and outdoor than indoor. The use of repellent cloths could add a supplementary yet significant role in reducing malaria and other vector-borne diseases such as chikungunya. Development of mosquito repellency-clothing technology which has patches and works like mosquitoes force fields is seen to have additional value towards the prevention of mosquito-borne diseases by initially repelling the mosquitoes and preventing blood-feeding on human hosts for both indoors and outdoors environments.
Vector-borne diseases (VBDs) cause significant morbidity and mortality worldwide, accounting for as much as 17% of the global infectious disease burden. Over one billion people are infected with VBDs annually and more than one million die from those infections each year. Development of mosquito repellency-clothing technology which has patches and works like mosquitoes force fields is seen to have additional value towards the prevention of mosquito-borne diseases by initially repelling the mosquitoes and preventing blood-feeding on human hosts for both indoors and outdoors.
- Prototype: A venture or organization building and testing its product, service, or business model
- A new application of an existing technology
Mosquito control using long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) has had a substantial impact on malaria transmission globally. However, deliberate scale up of LLINs and IRS has led to the emergence of behaviourally resilient malaria vectors that evade these tools by increasingly feeding and resting outdoors. These changes, associated with the suppression of the once prominent local vector attenuate the impact of LLINs and IRS. This shift in mosquito species composition and consequently to mosquito behaviour that define the biological limits of LLINs and IRS, coupled with practices that expose human hosts to outdoor mosquito biting have resulted in persistent malaria transmission outdoors (residual transmission).
Using clothing as a delivery format of spatial repellents will also overcome the challenge of limited mobility of recently developed emanator formats, that require the host to be within the treated air space of stationary emanators. Integrating insecticide into clothing that is locally made, low cost and worn ubiquitously across communities on a daily basis will likely promote uptake and the attendant effectiveness as it does not require any change in human behaviour. Also the product is long lasting, lasting for upto 20 washes has no potential for overuse, harmful if swallowed, not applied, Not harmful to your eyes and most importantly does not cause skin irritation.
Noobites cloth technology is a treated outfit with 48 repellent patches fixed into the material. Each repellent patch is treated with PMD extracted from Gum tree and Cymbopogon (lemon grass), fixed with high density 3D glossy ink to equalize the vapour pressure and increase the tenacity. Each patch contains approximately 1 g of lemon grass and 1 g of gum tree extract. Each cloth contains 16 patches, 4 patches around the wrist, 4 below the elbow, 4 above the elbow and 4 around the sleeve below the shoulder.
Here is the link of pictures when testing the technology in the laboratory https://twitter.com/noobites_Inc/status/1169596692754239489
- Behavioral Technology
- Biotechnology / Bioengineering
- Materials Science
Mosquito-repellent clothing technology in developing countries could play an important role in reducing malaria and other vector-borne diseases, including Dengue, Zika, and West Nile Virus which are all vectored by different mosquito species. A repellent clothing technology that is safe, cheap, and has none or little odour is desirable and this will ultimately be one which contains the lowest possible amount of active ingredients.
- Women & Girls
- Pregnant Women
- Infants
- Children & Adolescents
- Rural
- Poor
- Low-Income
- Middle-Income
- Refugees & Internally Displaced Persons
- 3. Good Health and Well-Being
- Tanzania
- Burundi
- Kenya
- Rwanda
- Uganda
We are currently validating our technology still not in the market.
Our Vision in 5 years is to make a difference in the lives of people globally through innovative health products. We are committed to being the premier, research-intensive biotech startup company and dedicated to providing leading innovations and solutions for today and the future.
Communication has been a challenge to us we are facing as a team, two of our co-founder they are not staying in Tanzania so it has been a problem and we currently don't have funds to make them relocate permanently in Tanzania where our startup is located.
We looking forward to have support in raising funds and relocate them to Tanzania.
- For-profit, including B-Corp or similar models
Gilbert Abel, CEO, experience in developing tools for mosquito control, 4 years in Product Development, Team Building & Performance and Health Care.
Aurore Imena, Chief Acquisition Officer , studied Commerce, Catholic University of Eastern Africa Nairobi-Kenya, experience as Strategic Account Management at BBDO Worldwide. Experienced in Financial analysis.
Sam Nyongesa Chief Design Officer, 7 years in Product Design, Fluent in Design, prototypes & Marketing.
Rose Respick, Chief Legal Officer, studied law at St Augustine university Tanzania, advocate pending admission 4 Years in Company affairs Commercial Legal Services & Intellectual property.
Noobites founding Team consists of four friends from 3 different countries Tanzania, Kenya and Rwanda who have a complimentary background in Healthcare, business, design and law, who come together and bound over a desire to solve the problem of mosquitoes borne diseases. we are Total 5, full Time 2, part-time, 2 contractor 1.
We work together with Ifakara Health Institute (IHI) a non profit leading research organization in Africa, with strong track records in developing, testing and validating innovations for health. It's where we are based.
Ifakara Health Institute (IHI) is a leading research organization in Africa, with strong track records in developing, testing and validating innovations for health.
Merck is a vibrant team of specialists in Healthcare, Life Science and Performance Materials. Merck shares a love of science and a passion for technology. The National Institute for Medical Research (NIMR) is the largest public health research institution in Tanzania.
We are going to partner with a local textile manufacturer by licensing the noobites technology to them at annual fees to produce clothing technology counting noobites solution. And we at noobites we focus on the science development side of the technology.
- Organizations (B2B)
We are looking only for grants support.
Am applying to solve to Inspire others in helping the world in finding better solutions to pollution, climate change and biodiversity loss in order to truly transform societies and economies.
- Business model
- Solution technology
- Board members or advisors
We believe that we can dramatically improve on disease control and environmentally friendly technology in low-income communities. we need to develop more our technology. Develop business model and having a strong board members or advisors.
We would like to partner with the MIT department of materials Science and Engineering in extending the limits of our developed product.
We believe that we can dramatically improve on disease control and environmentally friendly technology in low-income communities. And We will spend the funding support to validate this technology and develop it to scalable level. We will create and test the concept of using repellent textile technology a component of improved environmentally -friendly mosquito repellent with complementary advantage of mosquito control. We will identify the optimal treatment doses and a safe delivery mechanism for repellent textile to provide high levels of protection against mosquitoes borne-illness, for as long as possible, at an affordable cost and environmental-friendly amicable solution.
We believe that we can dramatically improve on disease control and environmentally friendly technology in low-income communities. And We will spend the funding support to validate this technology and develop it to scalable level. We will create and test the concept of using repellent textile technology a component of improved environmentally -friendly mosquito repellent with complementary advantage of mosquito control. We will identify the optimal treatment doses and a safe delivery mechanism for repellent textile to provide high levels of protection against mosquitoes borne-illness, for as long as possible, at an affordable cost and environmental-friendly amicable solution.
We believe that we can dramatically improve on disease control and environmentally friendly technology in low-income communities. And We will spend the funding support to validate this technology and develop it to scalable level. We will create and test the concept of using repellent textile technology a component of improved environmentally -friendly mosquito repellent with complementary advantage of mosquito control. We will identify the optimal treatment doses and a safe delivery mechanism for repellent textile to provide high levels of protection against mosquitoes borne-illness, for as long as possible, at an affordable cost and environmental-friendly amicable solution.
We believe that we can dramatically improve on disease control and environmentally friendly technology in low-income communities. And We will spend the funding support to validate this technology and develop it to scalable level. We will create and test the concept of using repellent textile technology a component of improved environmentally -friendly mosquito repellent with complementary advantage of mosquito control. We will identify the optimal treatment doses and a safe delivery mechanism for repellent textile to provide high levels of protection against mosquitoes borne-illness, for as long as possible, at an affordable cost and environmental-friendly amicable solution.
We believe that we can dramatically improve on disease control and environmentally friendly technology in low-income communities. And We will spend the funding support to validate this technology and develop it to scalable level. We will create and test the concept of using repellent textile technology a component of improved environmentally -friendly mosquito repellent with complementary advantage of mosquito control. We will identify the optimal treatment doses and a safe delivery mechanism for repellent textile to provide high levels of protection against mosquitoes borne-illness, for as long as possible, at an affordable cost and environmental-friendly amicable solution.

Researcher